NICE gives nod to some Herceptin use; ShareThis tool lets pharma do social media;

 @FiercePharma: The most (and least) efficient Big Pharma companies. Article | Follow @FiercePharma

> Britain's health cost watchdog has recommended the National Health Service should pay for Roche's cancer drug Herceptin in some cases for patients whose stomach cancer has spread. News

> The online tools company ShareThis says it has developed a new way for drugmakers to enable social-media sharing of their content without violating strict disclosure standards. ShareThis release

> The U.S. Supreme Court will consider a lower court ruling that barred a group of West Virginia plaintiffs from proceeding with a class-action lawsuit over Bayer's cholesterol-lowering drug Baycol, which was withdrawn from the market in 2001. Report

> Drugmakers will face new fines for failing to submit required pricing data on a timely basis to the Centers for Medicare & Medicaid Services. Article

> A U.S. judge dismissed Bayer's patent lawsuit against Watson Pharmaceuticals and Novartis' Sandoz unit, which are seeking to market generic versions of Bayer's Yasmin birth control pills. Article

> The FDA has issued a consumer alert to pet owners, warning them about the dangers of buying discounted pet drugs online. Item

Biotech News

 @FierceBiotech: Palatin cuts half its workforce, discovery R&D. Article | Follow @FierceBiotech

> Foster tapped as Creabilis CEO. News

> Lilly research chief outlines the perfect biotech pact. Item

> AZ pushes pedal to metal on PhIII oral RA blitzkrieg. Report

> Termeer says he's ready to go--when price and time are right. Story

> Judges offer ESC research programs a reprieve. News

Drug Delivery News

> Not a dry eye in the house for EyeGate, RXi partnership. Item

> Stirling talks to Big Pharma about aerosol delivery. Story

> Titan takes $5M loan for studies on opioid addiction treatment. Article

> E-cigarette advocates admit own claims brought wrath of FDA. News

> Sealing problem found in some Redipens. Story

Medical Device News 

 @FierceMedDev: Why Oct. 4 is a landmark day for the U.S. device industry? hint: bring a scalpel rather than a meat axe. Article | Follow @FierceMedDev

> Cordis: Cypher stent just as effective as Abbott rival. News

> 3M purchases Arizant for $810M. Story

> Abbott stent outperforms rival from Boston Sci. Report

> Medtronic, St. Jude to end dispute over employee. Story

> OptiNose aims high with nasal drug delivery device. Article

> Crocker Ventures buys TMJ Implants. Story

And Finally... The drug Tamiflu may have protected young adults who caught the H1N1 swine flu virus in 2009 from developing pneumonia, a study in China has found. Story